Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD Consortium
Ist Teil von
Neurology, 2022-08, Vol.99 (7), p.e698
Ort / Verlag
United States
Erscheinungsjahr
2022
Quelle
MEDLINE
Beschreibungen/Notizen
Considerable heterogeneity exists in the literature concerning genetic determinants of the age at onset (AAO) of Parkinson disease (PD), which could be attributed to a lack of well-powered replication cohorts. The previous largest genome-wide association studies (GWAS) identified
and
loci on chromosome (Chr) 4 with a significant influence on the AAO of PD; these have not been independently replicated. This study aims to conduct a meta-analysis of GWAS of PD AAO and validate previously observed findings in worldwide populations.
A meta-analysis was performed on PD AAO GWAS of 30 populations of predominantly European ancestry from the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (COURAGE-PD) Consortium. This was followed by combining our study with the largest publicly available European ancestry dataset compiled by the International Parkinson Disease Genomics Consortium (IPDGC).
The COURAGE-PD Consortium included a cohort of 8,535 patients with PD (91.9%: Europeans and 9.1%: East Asians). The average AAO in the COURAGE-PD dataset was 58.9 years (SD = 11.6), with an underrepresentation of females (40.2%). The heritability estimate for AAO in COURAGE-PD was 0.083 (SE = 0.057). None of the loci reached genome-wide significance (
< 5 × 10
). Nevertheless, the COURAGE-PD dataset confirmed the role of the previously published
variant as a genetic determinant of the AAO of PD with Bonferroni-corrected nominal levels of significance (
< 0.025): (rs34311866: β(SE)
= 0.477(0.203),
= 0.0185). The subsequent meta-analysis of COURAGE-PD and IPDGC datasets (N
= 25,950) led to the identification of 2 genome-wide significant association signals on Chr 4, including the previously reported
locus (rs983361: β(SE)
= 0.720(0.122),
= 3.13 × 10
) and a novel
locus (rs4698412: β(SE)
= -0.526(0.096),
= 4.41 × 10
).
Our study further refines the genetic architecture of Chr 4 underlying the AAO of the PD phenotype through the identification of
as a novel AAO PD locus. These findings open a new direction for the development of treatments to delay the onset of PD.